194 related articles for article (PubMed ID: 37324275)
21. Pituitary macroadenoma secreting thyrotropin and growth hormone: remission of bihormonal hypersecretion in response to lanreotide therapy.
Shimon I; Nass D; Gross DJ
Pituitary; 2001 Sep; 4(4):265-9. PubMed ID: 12501978
[TBL] [Abstract][Full Text] [Related]
22. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[TBL] [Abstract][Full Text] [Related]
23. TSH-STAINING PITUITARY ADENOMAS: RARE, SILENT, AND PLURIHOROMONAL.
Polanco Santos C; Sandouk Z; Yogi-Morren D; Prayson R; Recinos P; Kennedy L; Hamrahian AH; Pantalone KM
Endocr Pract; 2018 Jun; 24(6):580-588. PubMed ID: 29949434
[TBL] [Abstract][Full Text] [Related]
24. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
[TBL] [Abstract][Full Text] [Related]
25. The Endoscopic Endonasal Transsphenoidal Approach for Thyrotropin-Secreting Pituitary Adenomas: Single-Center Experience and Clinical Outcomes of 49 Patients.
Sen HE; Ceylan EC; Atayev S; Sozen M; Bayrak BY; Cetinarslan B; Anik Y; Icli AD; Cabuk B; Anik I; Ceylan S
World Neurosurg; 2022 Nov; 167():e1275-e1283. PubMed ID: 36096394
[TBL] [Abstract][Full Text] [Related]
26. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
[TBL] [Abstract][Full Text] [Related]
27. Clinical and morphological characteristics, diagnostic criteria, and outcomes of surgical treatment of TSH-secreting pituitary adenomas.
Astaf'eva LI; Kadashev BA; Shishkina LV; Kalinin PL; Fomichev DV; Kutin MA; Aref'eva IA; Dzeranova LK; Sidneva YG; Klochkova IS; Rotin DL
Zh Vopr Neirokhir Im N N Burdenko; 2016; 80(6):24-35. PubMed ID: 28139570
[TBL] [Abstract][Full Text] [Related]
28. The clinical presentation of PIT1 positive pituitary neuroendocrine tumor immunonegative for growth hormone, prolactin, and thyroid stimulating hormone with analysis of clinical and immunostaining dissociation.
Hong S; Shinya Y; Trejo-Lopez JA; Gruber LM; Erickson D; Bendok BR; Chaichana KL; Atkinson JL; Marino MJ; Donaldson AM; Stokken JK; Westphal SA; Chang AY; Samson SL; Choby GW; Van Gompel JJ
Clin Neurol Neurosurg; 2024 Jan; 236():108075. PubMed ID: 38056042
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic endonasal transsphenoidal surgery in elderly patients with pituitary adenomas.
Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Mota JI
J Neurosurg; 2015 Jul; 123(1):31-8. PubMed ID: 25839926
[TBL] [Abstract][Full Text] [Related]
30. [The surgery of thyrotropin-secreting pituitary adenomas and the significance of thyroid stimulating hormone level in follow-up].
Yang YY; Liu H; Hu A; Zou Y; Xing B; Yao Y; Wang RZ; Lian W
Zhonghua Yi Xue Za Zhi; 2016 Dec; 96(47):3825-3828. PubMed ID: 28057099
[No Abstract] [Full Text] [Related]
31. Gonadotropin-secreting and thyrotropin-secreting pituitary adenomas: A single-center experience.
Karlekar M; Diwaker C; Sarathi V; Lila A; Sharma A; Memon SS; Patil V; Bandgar T
Arch Endocrinol Metab; 2023 Nov; 68():e230072. PubMed ID: 37988667
[TBL] [Abstract][Full Text] [Related]
32. Patterns of extrasellar extension in growth hormone-secreting and nonfunctional pituitary macroadenomas.
Zada G; Lin N; Laws ER
Neurosurg Focus; 2010 Oct; 29(4):E4. PubMed ID: 20887129
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma.
Wu YY; Chang HY; Lin JD; Chen KW; Huang YY; Jung SM
J Formos Med Assoc; 2003 Mar; 102(3):164-71. PubMed ID: 12783133
[TBL] [Abstract][Full Text] [Related]
34. Clinical and Therapeutic Characteristics of Pituitary TSH-Secreting Adenoma in Adolescent-Onset Patients: Six Case Studies and Literature Review.
Yang Y; Liu J; Deng K; Lu L; Zhu H; Lian X; Bao X; Duan L; Yao Y
Front Endocrinol (Lausanne); 2021; 12():771673. PubMed ID: 35002961
[TBL] [Abstract][Full Text] [Related]
35. Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone-secreting pituitary adenomas.
Kim SH; Ku CR; Na M; Yoo J; Kim W; Jung IH; Kim KW; Moon JH; Kim D; Lee EJ; Kim SH; Kim EH
J Neurosurg; 2020 Mar; 134(3):794-800. PubMed ID: 32168476
[TBL] [Abstract][Full Text] [Related]
36. Case Report: A Case of Pituitary Adenoma Producing Growth Hormone and Thyroid-Stimulating Hormone Simultaneously.
Sanada J; Tatsumi F; Kamei S; Fushimi Y; Shimoda M; Kohara K; Nakanishi S; Kaku K; Mune T; Kaneto H
Front Endocrinol (Lausanne); 2021; 12():659076. PubMed ID: 33828533
[TBL] [Abstract][Full Text] [Related]
37. Response of a GH- and TSH-secreting pituitary adenoma to a somatostatin analogue (SMS 201-995): evidence that GH and TSH coexist in the same cell and secretory granules.
Malarkey WB; Kovacs K; O'Dorisio TM
Neuroendocrinology; 1989 Mar; 49(3):267-74. PubMed ID: 2716953
[TBL] [Abstract][Full Text] [Related]
38. Early recognition of aggressive pituitary adenomas: a single-centre experience.
Ceccato F; Regazzo D; Barbot M; Denaro L; Emanuelli E; Borsetto D; Rolma G; Alessio L; Gardiman MP; Lombardi G; Albiger N; D'Avella D; Scaroni C
Acta Neurochir (Wien); 2018 Jan; 160(1):49-55. PubMed ID: 29170844
[TBL] [Abstract][Full Text] [Related]
39. Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients.
Chanson P; Weintraub BD; Harris AG
Ann Intern Med; 1993 Aug; 119(3):236-40. PubMed ID: 8323093
[TBL] [Abstract][Full Text] [Related]
40. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
Sanno N; Teramoto A; Matsuno A; Takekoshi S; Osamura RY
J Clin Endocrinol Metab; 1995 Aug; 80(8):2518-22. PubMed ID: 7543115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
